Publications and Presentations

Nov. 01, 2023

Taurolidine/Heparin Lock Solution and Catheter-Related Bloodstream Infection in Hemodialysis: A Randomized, Double-Blind, Active-Control, Phase 3 Study

Oct. 20, 2021

Incremental Cost of Catheter related Bloodstream Infections among Central Venous Catheter Dependent Hemodialysis Patients: A Claims Based Assessment of USRDS Linked Medicare Data

Nov. 4 – Nov. 7, 2021

Hospitalization Risk and Long-term Complications Associated with Catheter Related Bloodstream Infections Among Hemodialysis Patients

Nov. 4 – Nov. 7, 2021

Catheter Related Bloodstream Infections Incidence and Associated Mortality Risk: Analysis of Merged United States Renal Data System Medicare Claims

PRE-CLINICAL ABSTRACT AT THE ANNUAL MEETING OF AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO)

May 10, 2019

LOCK-IT 100 NKF Presentation As Presented May 10 2019

December 6, 2017

Postmarketing experience with Neutrolin® (taurolidine, heparin, calcium citrate) catheter lock solution in hemodialysis patients

2014

Möglichkeiten zur Verringerung von Bakteriämierisiken bei Verwendung von getunnelten zentralvenösen Dialysekathetern

July 2014

Tunneled Catheters with Taurolidine-Citrate-Heparin Lock Solution Significantly Improve the Inflammatory Profile of Hemodialysis Patients

2002

Prevention of Hemodialysis Catheter-Related Bloodstream Infection Using an Antimicrobial Lock

2013

Central Venous Catheters and Catheter Locks in Children With Cancer: A Prospective Randomized Trial of Taurolidine Versus Heparin

April 14, 2009

Taurolidine lock is highly effective in preventing catheter-related bloodstream infections on patients on home parenteral nutrition: A heparin-controlled prospective trial